EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Purpose: Constitutive Wnt signaling caused by mutations in the β-catenin gene is a molecular hallmark of adamantinomatous craniopharyngiomas (adaCP) and promotes infiltration into adjacent brain tissue. Herein, we studied the pathogenic role of epidermal growth factor receptor (EGFR) activation in adaCP and whether tumor cell migration can be inhibited by the tyrosine kinase inhibitor gefitinib. Experimental Design: EGFR expression and activation [phosphorylated EGFR (EGFR-P)] was examined in a cohort of 25 surgical adaCP samples by PCR and Western blotting. Regional and cellular localization patterns of EGFR-P, β-catenin, and its target gene product Fascin were determined by immunofluorescence microscopy. Mutation analysis and gene copy number assay were carried out to examine genetic alterations in the EGFR gene. The impact of EGFR signaling on tumor cell migration was studied in vitro by using 11 primary human adaCP cultures treated with the EGFR ligand EGF and its inhibitor gefitinib. Results: Neither mutations nor amplifications in the EGFR gene were detected in our adaCP series. However, EGFR-P was detectable in tumor cell clusters located at the brain infiltration border and colocalized with nuclear β-catenin and Fascin. Activated EGFR significantly promoted tumor cell migration in vitro, whereas gefitinib reduced both tumor cell motility and Fascin expression. Conclusion: Our data suggest EGFR signaling to play a role in cell migration and brain infiltration of adaCP. Targeting the EGFR signaling pathway by gefitinib may present a promising pharmacologic option in the treatment of this challenging tumor disease. Clin Cancer Res; 17(13); 4367–77. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
Karavitaki, N., Brufani, C., Warner, J. T., Adams, C. B. T., Richards, P., Ansorge, O., Shine, B., Turner, H. E., & Wass, J. A. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02231.x · Cited by 633 · cited 2×
“Following partial tumor removal and radiotherapy, recent series reported a 10-year recurrencefree survival rate of 81% to 91%, with 46% to 58% of the survivors living a normal independent life (1).”
BackgroundInfluentialKaravitaki, N., Cudlip, S., Adams, C. B. T., & Wass, J. A. H. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0002 · Cited by 514
Cited by
Andoniadou, C. L., Gaston-Massuet, C., Reddy, R., Schneider, R. P., Blasco, M. A., Le Tissier, P., Jacques, T. S., Pevny, L. H., Dattani, M. T., & Martinez-Barbera, J. P. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0957-9 · Cited by 207
“Recent evidence points towards a role in tumour progression and invasiveness into the brain [8, 27–29].”
BackgroundApps, J. R., Carreno, G., Gonzalez-Meljem, J. M., Haston, S., Guiho, R., Cooper, J. E., Manshaei, S., Jani, N., Hölsken, A., Pettorini, B., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1830-2 · Cited by 189
Self-citationZhao, X., Gao, S., Ren, H., Sun, W., Zhang, H., Sun, J., Yang, S., & Hao, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3009 · Cited by 163
Tumour suppressor TRIM33 targets nuclear β-catenin degradation
Xue, J., Chen, Y., Wu, Y., Wang, Z., Zhou, A., Zhang, S., Lin, K., Aldape, K., Majumder, S., Lu, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7156 · Cited by 160
Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
Martinez-Barbera, J. P., & Buslei, R. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0442 · Cited by 45
Self-citation
Metadata
- Authors
- Hölsken, A., Gebhardt, M., Buchfelder, M., Fahlbusch, R., Blümcke, I., & Buslei, R.
- Venue
- Clinical Cancer Research
- Published
- 2011-07-01
- Volume
- 17
- Issue
- 13
- Pages
- 4367-4377
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2110724268
- Cited by
- 96
- References
- 2
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-2811
- The paper
- Hölsken, A., Gebhardt, M., Buchfelder, M., Fahlbusch, R., Blümcke, I., & Buslei, R. (2011). EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-2811
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.